You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


AZ’s COVID-19 vaccine trial resumes in Japan

A phase I/II clinical trial for AstraZeneca’s Oxford University-partnered COVID-19 vaccine AZD1222 has resumed in Japan, following the restart of trials in the UK, Brazil, South Africa and India.